Have you read these stories?

Johnson & Johnson starts phase 3 vaccine trial

US drugmaker Johnson & Johnson says the vaccine could be available for use by early 2021 if proven safe, effective. In the next phase ...
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 24 September, 2020, 04:59 AM IST | E-Paper
Search
+

    SEARCHED FOR:GLOBAL HEADWINDS

    India's long-term growth story robust despite global headwinds: Report

    According to Dun & Bradstreet's Economy Forecast, the balance sheet of banks, corporate and government remains strained while the gross non-performing assets (NPAs) have increased significantly.

    Multiple economic headwinds cloud profit outlook for Indian companies

    The country’s economic growth slumped to a five-year low of 5.8 per cen...

    Global growth worries, geopolitical headwinds give gold a lot to cheer

    Gold futures are expected to test next resistance zone of $1,245-1,250...

    Load More...
    x
    The Economic Times